Behavioural Brain Research 2012-08-01

Involvement of neurotransmitters in the action of growth hormone-releasing hormone antagonist on passive avoidance learning.

Gyula Telegdy, Andrew V Schally

Index: Behav. Brain Res. 233(2) , 326-30, (2012)

Full Text: HTML

Abstract

The antagonist MZ-4-71 of growth hormone-releasing hormone (GH-RH) has been shown to suppress the secretion of GH and insulin-like growth factor-1 (IGF-1), suggesting that this class of analogs could be used for the therapy of disorders characterized by excessive GH secretion. Numerous GH-RH antagonists has been synthetized and shown to suppress the growth of various tumors. MZ-4-71 facilitates the consolidation of passive avoidance learning. Beta-amyloid 25-35 impairs the consolidation of passive avoidance learning and MZ-4-71 fully blocks this impairment. However, little is known about the possible mechanism of action of GR-RH antagonists on these actions. In the present work, the possible effects of different neurotransmitters on the action of MZ-4-71 were studied in the memory consolidation of passive avoidance behavior. The involvement of cholinergic, serotonergic, dopaminergic, GABA-ergic, adrenergic and opiate receptors was tested. Mice were pretreated with a nonselective α-adrenergic receptor antagonist, phenoxybenzamine, a β-adrenergic receptor antagonist, propranolol, a mixed 5-HT1/5-HT2 serotonergic receptor antagonist, methysergide, a nonselective 5-HT2 serotonergic receptor antagonist, cyproheptadine, a nonselective muscarinic acetylcholine receptor antagonist, atropine, a D2, D3, D4 dopamine receptor antagonist, haloperidol, a γ-aminobutyric acid subunit A (GABA-A) receptor antagonist, bicuculline, or a nonselective opioid receptor antagonist, naloxone. Atropine, methysergide, cyproheptadine and naloxone prevented the effects of MZ-4-71 on passive avoidance learning, whereas haloperidol, phenoxybenzamine, propranolol and bicuculline did not change the effects of MZ-4-71. The results demonstrate that the muscarinic acetylcholine receptor, the 5-HT1/5-HT2 serotonergic receptor and opioid receptors are involved as mediators in the action of MZ-4-71 on the consolidation of passive avoidance learning.Copyright © 2012 Elsevier B.V. All rights reserved.


Related Compounds

Related Articles:

Neurotransmitter-mediated action of an antagonist of growth hormone-releasing hormone on anxiolysis in mice

2012-07-15

[Behav. Brain Res. 233(1) , 232-6, (2012)]

Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer.

2013-02-15

[Int. J. Cancer 132(4) , 755-65, (2013)]

Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers.

2012-02-01

[Cancer 118(3) , 670-80, (2012)]

Effects of the growth hormone-releasing hormone (GH-RH) antagonist on brain functions in mice.

2011-10-10

[Behav. Brain Res. 224(1) , 155-8, (2011)]

Growth hormone releasing hormone (GHRH) signaling modulates intermittent hypoxia-induced oxidative stress and cognitive deficits in mouse.

2013-11-01

[J. Neurochem. 127(4) , 531-40, (2013)]

More Articles...